Browse All

Current Filters

CLEAR FILTER x

TITLE

An Investigator Initiated Study of KYV-101, a CD19 CAR T Cell Therapy, in Participants with Treatment Refractory Progressive Multiple Sclerosis

Author:Gupta, Sasha   Seshadri, Madhav   Lincoln, Robin   Okinishi, Naomi   Shum, Nancy   Shenoy, Samantha   Wilmoth, Jenai   Hauser, Stephen   Cree, Bruce   

Session Name:S3: Multiple Sclerosis: Clinical Trials  

Topic:Multiple Sclerosis  

Program Number:S3.002  

Author Institution:University of California, San Francisco, San Francisco, CA  University of California San Francisco, San Francisco, CA  

Enhanced Safety Profile of Ocrelizumab Over Rituximab in Multiple Sclerosis Treatment

Author:Cerono, Gabriel   Cree, Bruce   Hauser, Stephen   Baranzini, Sergio   

Session Name:P8: Multiple Sclerosis: Disease-modifying Therapies: Real-world Evidence and Adverse Events 2  

Topic:Multiple Sclerosis  

Program Number:P8.006  

Author Institution:UCSF, San Francisco, CA  UCSF, Multiple Sclerosis Center, San Francisco, CA  UCSF Weill Institute for Neurosciences, San Francisco, CA  

Five Years of Ublituximab in Relapsing Multiple Sclerosis: Additional Results from Open-label Extension of ULTIMATE I and II Studies

Author:Cree, Bruce   Fox, Edward   Hartung, Hans-Peter   Alvarez, Enrique   Qian, Peiqing   Wray, Sibyl   Robertson, Derrick   Huang, Deren   Selmaj, Krzysztof   Wynn, Daniel   Mok, Koby   Hsu, Yanzhi   Xu, Yihuan   Rowland, Chris   Bodhinathan, Karthik   Sportelli, Peter   Parker, Jackie   Misk,   

Session Name:P11: Multiple Sclerosis: Clinical and Translational Research in MS 1  

Topic:Multiple Sclerosis  

Program Number:P11.006  

Author Institution:UCSF, Multiple Sclerosis Center, San Francisco, CA  TG Therapeutics, Morrisville, NC  Heinrich Heine University Medical Faculty, Dusseldorf, Germany  University of Colorado, Aurora, CO  Swedish Medical Center, Seattle, WA  Hope Neurology, Knoxville, TN  University of South Florida, Tampa, FL  Licking Memorial Hospital, Powell, OH  University of Warmia and Mazury, Lodz, Poland  Consultants in Neurology, Ltd., Northbrook, IL  TG Therapeutics, Seal Beach, CA  TG Therapeutics, Oviedo, FL  TG Therapeutics, Lexington, MA  TG Therapeutics, New York, NY  Stanford Medicine, Stanford, CA  

Efficacy and Safety of Inebilizumab Among Non-White Demographic Groups with Neuromyelitis Optica Spectrum Disorder: N-MOmentum Study Subgroup Analysis

Author:Paul, Friedemann   Fujihara, Kazuo   Avila, Marila   Wu, Yanping   Patterson, Kristina R.   Cimbora, Daniel   Cree, Bruce   

Session Name:P11: Autoimmune Neurology: NMOSD and MOGAD 2  

Topic:Autoimmune Neurology  

Program Number:P11.007  

Author Institution:Charite Universitatsmedizin in Berlin, Berlin, Germany  Tohoku University, School of Medicine, Sendai, Japan  UCSF Weill Institute for Neurosciences, University of California San Francisco, San Francisco, CA  

Adherence to Biologic Therapies Among Patients with Neuromyelitis Optica Spectrum Disorder (NMOSD) in the United States

Author:Cree, Bruce   Patterson, Kristina R.   Meyers, Andrea   Gagnon-Sanschagrin, Patrick   Maitland, Jessica   Park, Jenny Y.   

Session Name:P11: Autoimmune Neurology: NMOSD and MOGAD 2  

Topic:Autoimmune Neurology  

Program Number:P11.016  

Author Institution:UCSF, Multiple Sclerosis Center, San Francisco, CA  Analysis Group, Inc., Montreal, QC, Canada